ArticleFrontiers in pediatrics2025
The predictive value of urinary albumin-to-creatinine ratio for coronary artery abnormalities in Kawasaki disease.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A triad of hypertension, heart failure, and glomerular injury in subacute Kawasaki disease: a case report and literature review.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To explore the application value of the urinary albumin-to-creatinine ratio (UACR) in the predictive of coronary artery (CA) abnormalities in Kawasaki disease (KD) during acute phase. Methods: This retrospective study included 109 KD patients who were stratified into CA abnormalities and normal CA groups based on echocardiography at one month after KD onset. Clinical, demographic, and laboratory data were analyzed. Urinary microalbumin and urinary creatinine values were collected during the acute phase before high-dose intravenous immunoglobulin (IVIG) therapy, and UACR was calculated. Results: The 109 patients consisted of 70 males and 39 females. The orrelation analysis revealed no significant associations between UMA and serum albumin (Alb) ( Conclusions: UACR and serum Alb, assessed during the acute phase of KD, could serve as early biomarkers for CA abnormalities, particularly when analyzed in combination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.